-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PY/nFHxS+X/ux+skczzY+S42Uq3DoR7hjKgwVdiui4icINfzvLDtYg3QzDYj5UYE QbWsxZ6Y31iMmU19fitx7g== 0001180603-05-000002.txt : 20050611 0001180603-05-000002.hdr.sgml : 20050611 20050526100938 ACCESSION NUMBER: 0001180603-05-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050518 FILED AS OF DATE: 20050526 DATE AS OF CHANGE: 20050526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOX MARYE ANNE CENTRAL INDEX KEY: 0001180603 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 05858411 BUSINESS ADDRESS: BUSINESS PHONE: 9197543300 X44403 MAIL ADDRESS: STREET 1: C/O RED HAT, INC STREET 2: 1801 VARSITY DRIVE CITY: RALEIGH STATE: NC ZIP: 27606 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-05-18 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001180603 FOX MARYE ANNE 1530 SOLEDAD AVENUE LA JOLLA CA 92037 1 0 0 0 Common Stock 1580 D Stock Options (to buy) 47.58 2005-05-18 4 A 0 2729 0 A 2005-05-18 2015-05-17 Common Stock 2729 24729 D 1,580 shares are restricted stock exempt under Rule 16(b)(3). Lisa C. Noecker attorney in fact for Marye Anne Fox 2005-05-26 -----END PRIVACY-ENHANCED MESSAGE-----